Epidarex Capital Leads Initial Investment in International Diabetes Start Up
November 4, 2015
Glasgow, United Kingdom, November 4th 2015 – Caldan Therapeutics Ltd (Caldan) has announced a £4.45 million ‘Series A’ investment led by Epidarex Capital, a leading